NYSE:VICI
NYSE:VICISpecialized REITs

VICI Properties (NYSE:VICI) Announces US$0 Dividend Per Share for Q1 2025

VICI Properties (NYSE:VICI) recently declared a regular quarterly cash dividend of $0.43 per share, likely influencing its share price movement, which rose 7% in the past month. The dividend announcement, alongside the company's strategic partnership with Cain International and Eldridge Industries LLC for the One Beverly Hills development, reflects VICI's commitment to shareholder value and growth in the real estate sector. Despite a dip in their fourth-quarter net income, the annual...
NasdaqGS:CRWD
NasdaqGS:CRWDSoftware

CrowdStrike Holdings (NasdaqGS:CRWD) Partners With Arrow Electronics To Expand Falcon Platform In North America

CrowdStrike Holdings (NasdaqGS:CRWD) experienced a price movement of 4.9% over the last quarter. During this period, the company's strategic initiatives, such as the newly announced distribution agreement with Arrow Electronics, aimed to bolster its channel partnerships and expand the availability of its Falcon cybersecurity platform. Despite these efforts, the broader market landscape presented challenges. Economic concerns, especially those related to tariffs and a weaker-than-expected jobs...
NYSE:SNOW
NYSE:SNOWIT

Snowflake (NYSE:SNOW) Welcomes Mike Gannon As New Chief Revenue Officer Effective March 14

Snowflake (NYSE:SNOW) announced the appointment of Mike Gannon as its new Chief Revenue Officer, signaling a shift in its leadership strategy. This move, which coincides with the recent client collaboration with Strata Decision Technology to enhance healthcare analytics, holds potential for growth but also follows a tumultuous market week. Over the past week ending March 7, 2025, the company's shares fell by 10.06%, a decline possibly exacerbated by broader market apprehensions as the Dow...
NasdaqGS:APP
NasdaqGS:APPSoftware

AppLovin (NasdaqGS:APP) Faces Class Action Amid Allegations Of Ad Fraud And Unethical Practices

AppLovin (NasdaqGS:APP) has experienced an 18.99% decline in its share price over the last week, coinciding with serious legal and ethical challenges. A class action lawsuit was filed against AppLovin and its officers, alleging misleading financial disclosures and potentially fraudulent practices related to its AXON 2.0 platform and AI technologies. Furthermore, a report by Fuzzy Panda Research accused the company of ad fraud and unethical data practices, exacerbating concerns and...
NasdaqGS:DUOL
NasdaqGS:DUOLConsumer Services

Duolingo (NasdaqGS:DUOL) Shares Drop 26% Despite Strong Q4 2024 Results

Duolingo (NasdaqGS:DUOL) recently announced strong fourth-quarter and full-year 2024 results, with sales and net income significantly increasing year-over-year. Despite this, the company's share price dropped 26% over the last quarter. The launch of new product enhancements, such as video call features in additional languages, signals a focus on user engagement. As market concerns about economic conditions, tariffs, and a lackluster jobs report pressured major indices, with the Nasdaq...
NasdaqGS:FANG
NasdaqGS:FANGOil and Gas

Diamondback Energy (NasdaqGS:FANG) Prices US$1200M Notes At 6 Percent To Fund Acquisition

Diamondback Energy (NasdaqGS:FANG) recently announced a $1.2 billion notes offering with funds allocated for an acquisition and corporate expenditures. Despite these strategic financial moves, Diamondback's share price declined 10% over the past week. This trend correlates with a broader market downturn, as major indices such as the Dow and S&P 500 experienced potential historic weekly losses amid economic uncertainties and tariff concerns. Factors outside Diamondback’s control, such as a...
NasdaqGS:MRNA
NasdaqGS:MRNABiotechs

Moderna (NasdaqGS:MRNA) Rises 10% Despite US$1 Billion Revenue Drop Prediction

Moderna (NasdaqGS:MRNA) recently experienced a notable 10% price increase over the last week amidst significant legal and financial developments. Genevant Sciences and Arbutus Biopharma have expanded their patent litigation against Moderna internationally, targeting its lipid nanoparticle technology, which could impact products like Spikevax and mRESVIA. Against this challenging backdrop, the company has kept its earnings guidance unchanged, projecting annual revenue between $1.5 billion and...
NasdaqGS:NTNX
NasdaqGS:NTNXSoftware

Nutanix (NasdaqGS:NTNX) Eyes Tuck-In Acquisitions With US$200 Million Share Buyback Plan

Nutanix (NasdaqGS:NTNX) has seen a 5% increase in its stock price over the last quarter, amid a challenging market backdrop. The company's pursuit of acquisitions, as highlighted by its interest in incorporating technology such as D2iQ into its offerings, has been instrumental in bolstering its position. Nutanix's ongoing focus on share buybacks, with $200 million still authorized for repurchase, signifies a commitment to enhance shareholder value. Additionally, strong earnings reports with a...
NYSE:FUBO
NYSE:FUBOInteractive Media and Services

fuboTV (NYSE:FUBO) Surges 76% Following Q3 Revenue Rise To US$1,623 Million

fuboTV (NYSE:FUBO) recently reported a 75% share price increase over the last quarter, despite broader market downturns with the Dow and S&P 500 experiencing significant declines. The company's improved financial results, reporting increased revenue of USD 1,623 million and reduced net losses from the previous year, likely played a part. The launch of CHCH TV and expanded distribution of Fubo Sports also added value, reinforcing content and reach. These strategic moves juxtaposed with a...
NasdaqGS:OKTA
NasdaqGS:OKTAIT

Okta (NasdaqGS:OKTA) Surges 31% As Revenue Hits US$682 Million

Okta (NasdaqGS:OKTA) experienced a significant 31% increase in its share price over the last quarter. This robust price movement aligns with the company's strong financial performance, as outlined in its latest earnings announcement on March 3, 2025. With revenue rising to $682 million and a net income of $23 million, compared to a net loss previously, Okta's improved profitability likely bolstered investor confidence. Additionally, the strategic partnership with Incode Technologies to...
BATS:CBOE
BATS:CBOECapital Markets

Cboe Global Markets (BATS:CBOE) Elevates Tim Lipscomb To Executive VP Driving Tech Innovation Globally

Cboe Global Markets (BATS:CBOE) experienced a 4% price increase over the last quarter, coinciding with significant executive leadership changes and technological advancements. The promotion of Tim Lipscomb to Executive Vice President and Chief Technology Officer reflects the company's focus on leveraging technology for growth, which has been demonstrated by successful platform migrations and improved global uptime. These changes may reassure investors about the company's commitment to...
NasdaqGS:AVGO
NasdaqGS:AVGOSemiconductor

Broadcom (NasdaqGS:AVGO) Reports Q1 Sales Surge To US$15 Billion Announces US$1 Dividend

Broadcom (NasdaqGS:AVGO) recently reported earnings that showcased a significant rise in sales to USD 14.92 billion and net income soaring to USD 5.5 billion, alongside a confirmation of upbeat guidance for the following quarter. The board also reaffirmed a quarterly dividend of USD 0.59 per share. Despite these strong financial performances, the company's stock experienced a minor price shift of 0.04% over the last quarter. This may be partially linked to market conditions marked by broad...
NYSE:TDOC
NYSE:TDOCHealthcare Services

Teladoc Health (NYSE:TDOC) Partners With Eli Lilly To Enhance Pharmacy Access For Weight Care Program

Teladoc Health (NYSE:TDOC) recently announced a pharmacy integration agreement with Eli Lilly, which aims to enhance access to GLP-1 medications for obesity as part of their Comprehensive Weight Care Program. This initiative, along with the unveiling of new capabilities for its care delivery platform, Prism, marks significant progress in the company's service enhancement efforts. Despite these positive developments, Teladoc Health's share price experienced a decline of 1.16% over the past...